Cognitive profiling and proteomic analysis of the modafinil analogue S-CE-123 in experienced aged rats

István Gyertyán, Jana Lubec, Alíz Judit Ernyey, Christopher Gerner, Ferenc Kassai, Predrag Kalaba, Kata Kozma, Iva Cobankovic, Gábor B. Brenner, Judith Wackerlig, Eva Franschitz, Ernst Urban, Thierry Langer, Jovana Maliković, Gert LübecScientific 2021 · DOI

TL;DR

This study investigates the cognitive effects of S-CE-123, a novel analogue of modafinil, in aged rats using a sophisticated cognitive test battery. The findings reveal that S-CE-123 enhances motivation and social cognition without impairing attention or learning, mirroring modafinil's profile and suggesting translational validity for the testing system. Proteomic analysis further links these behavioral changes to alterations in synaptic function and antioxidant pathways.

What Problem Does This Paper Address?

Developing effective cognitive enhancers for conditions like ADHD or age-related cognitive decline is challenging, partly due to the limitations of traditional animal models in predicting human outcomes. The authors highlight the need for animal assays with improved "translational validity" – meaning their results are more likely to reflect what would happen in humans. Specifically, they aim to evaluate S-CE-123, a compound designed for higher specificity and potency than modafinil, in a complex, multi-task rodent cognitive system that mimics human cognitive domains. This system is intended to be more predictive by using aged, experienced animals that have already learned multiple tasks, a scenario closer to real-world human cognitive challenges.

Methods

The study employed a multi-faceted approach combining behavioral testing with proteomic analysis.

  • Cognitive Profiling: Twenty-seven aged male Lister Hooded rats (26 months old) were used. These rats had prior experience with several learning tasks, including:
  • 5-choice serial reaction time test (5-CSRTT): Assesses sustained attention.
  • Morris water-maze (MWM): Evaluates spatial learning and memory.
  • Cooperation task: Models social cognition.
  • Pot jumping task: Measures motor learning.
  • Nose-poke: lever-press discrimination (NP-LP): A novel operant task to assess learning of new associations and motivation.
  • Motor activity monitor: To assess general activity levels.

    Rats were subchronically treated (15 days) with either S-CE-123 (10 mg/kg) or vehicle via intraperitoneal injection. The testing was conducted in a blinded, randomized manner. A complex experimental design involved increasing task difficulty and introducing novel tasks to challenge the animals' cognitive abilities.

  • Proteomic Analysis: Following behavioral testing, synaptosomal fractions from the prefrontal cortex (PFC) were collected. Label-free quantitative proteomics (LC-MS/MS) was used to identify and quantify protein changes between the CE-123 treated and vehicle groups. Bioinformatic analysis, including Gene Ontology (GO) enrichment, was performed to understand the functional implications of these protein alterations.

Datasets

Not applicable. This study generated its own behavioral and proteomic data from animal experiments. No external datasets were used for training or evaluation.

Key Insights and Ideas

  • Enhanced Motivation is Key: The most striking finding is the significant enhancement of motivation in CE-123 treated rats. This was evident across multiple tasks, including increased initiated trials in operant tasks and a greater willingness to engage with novel challenges. This suggests CE-123 might act as a "motivational enhancer."
  • Translational Relevance: The cognitive profile of CE-123 in aged rats closely resembles that of modafinil in humans, particularly in its effects on motivation and executive functions. This supports the idea that the complex, multi-task testing system used in this study has good translational validity for predicting cognitive effects.
  • Synaptic Plasticity and Antioxidant Defense: Proteomic analysis revealed significant changes in proteins related to synaptic vesicle recycling, synapse organization, and antioxidant activity. This provides a molecular basis for the observed behavioral improvements, suggesting that CE-123 may promote neuronal health and function.
  • Aging and Neurodegeneration Link: Many of the differentially expressed proteins were associated with aging and neurodegenerative diseases (e.g., ApoE, S100B, alpha-synuclein). Modulating these proteins could be a mechanism by which CE-123 exerts its effects, potentially offering benefits beyond simple cognitive enhancement.
  • Impulsivity Signal: A mild, transient increase in impulsivity (indicated by premature responses in the 5-CSRTT) was observed, which is a nuanced finding that warrants further investigation, especially given modafinil's context-dependent effects on impulsivity.

Key Results

  • Behavioral:
    • CE-123 significantly enhanced motivation, leading to superior performance in a novel operant discrimination task and a social cooperation assay.
  • Attention, spatial learning, and motor learning were not significantly affected by CE-123.
  • A mild, transient increase in impulsivity was observed in the 5-CSRTT.
  • No significant differences were found in the Morris water-maze, possibly due to a "ceiling effect" in this well-learned task.
  • Proteomic:
    • 182 protein groups were significantly different between CE-123 and vehicle-treated groups in the prefrontal cortex synaptosomal fraction.
  • Key functional categories enriched included synaptic vesicle recycling, synapse organization, and antioxidant activity.
  • Proteins associated with aging and neurodegeneration (e.g., ApoE, S100B, alpha-synuclein) were modulated.

Limitations and Future Work

  • Sex Differences: The study was conducted only in male rats. Future work should investigate potential sex-specific effects of CE-123, as modafinil has shown sex differences in some studies.
  • Single Dose/Duration: The study used a single dose (10 mg/kg) and a 15-day treatment period. Further dose-response studies and longer-term investigations would be beneficial.
  • No "CE-123 Only" Control: The authors acknowledge that a group receiving CE-123 without behavioral intervention would have been ideal to isolate the drug's effects from the training itself. However, this was not feasible due to the limited number of subjects.
  • Mechanistic Specificity: While proteomic data points to specific pathways, further research is needed to causally link these protein changes to the observed behavioral outcomes.
  • Direct Modafinil Comparison: A direct comparison of CE-123 and modafinil within the same test system and animal cohort would be valuable to confirm the proposed similarities and differences.

Summary updated

Abstract

The lack of novel cognitive enhancer drugs in the clinic highlights the prediction problems of animal assays. The objective of the current study was to test a putative cognitive enhancer in a rodent cognitive test system with improved translational validity and clinical predictivity. Cognitive profiling was complemented with post mortem proteomic analysis. Twenty-seven male Lister Hooded rats (26 months old) having learned several cognitive tasks were subchronically treated with S-CE-123 (CE-123) in a randomized blind experiment. Rats were sacrificed after the last behavioural procedure and plasma and brains were collected. A label-free quantification approach was used to characterize proteomic changes in the synaptosomal fraction of the prefrontal cortex. CE-123 markedly enhanced motivation which resulted in superior performance in a new-to-learn operant discrimination task and in a cooperation assay of social cognition, and mildly increased impulsivity. The compound did not affect attention, spatial and motor learning. Proteomic quantification revealed 182 protein groups significantly different between treatment groups containing several proteins associated with aging and neurodegeneration. Bioinformatic analysis showed the most relevant clusters delineating synaptic vesicle recycling, synapse organisation and antioxidant activity. The cognitive profile of CE-123 mapped by the test system resembles that of modafinil in the clinic showing the translational validity of the test system. The findings of modulated synaptic systems are paralleling behavioral results and are in line with previous evidence for the role of altered synaptosomal protein groups in mechanisms of cognitive function.
BibTeX
@inproceedings{gyertyan2021cognitive,
  author = {István Gyertyán and Jana Lubec and Alíz Judit Ernyey and Christopher Gerner and Ferenc Kassai and Predrag Kalaba and Kata Kozma and Iva Cobankovic and Gábor B. Brenner and Judith Wackerlig and Eva Franschitz and Ernst Urban and Thierry Langer and Jovana Maliković and Gert Lübec},
  title = {{Cognitive profiling and proteomic analysis of the modafinil analogue S-CE-123 in experienced aged rats}},
  booktitle = {Scientific},
  year = {2021},
  doi = {10.1038/s41598-021-03372-y},
}
Figure